Forcing biopharmaceutical companies to locate operations within countries as a condition of market access could undermine both investment and access to medicines.
This is a statement of principles on medicines procurement collectively issued by think tanks from Argentina, Brazil, Chile, Colombia and Mexico.
As the 2020 World Health Assembly re-convenes in Geneva, an international coalition of think tanks urges governments to commit to simple reforms to accelerate access to medicines, including those in the process of being developed for Covid-19.
La siguiente es una declaración de principios sobre la compra de medicamentos emitida en conjunto por centros de estudios de Argentina, Brasil, Chile, Colombia y México.
90% of medicines on the World Health Organization’s Model List of Essential Medicines are off-patent, while many low-income countries have no essential medicine patents at all, according to this Geneva Network research paper.
Somos una coalición internacional de institutos de investigación de políticas públicas y grupos de reflexión que cree que la colaboración, el comercio libre y la innovación son cruciales para la respuesta al Covid-19.
Improving access to medicines and quality healthcare remains a key area of action for the member states of the United Nations.
